Tokyo Tape
Sign in
← Qol Holdings

Quarterly report · Q2

3034.TEDINET S100PL5A
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥82.5bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥166.2bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥81.8bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥4.0bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥4.2bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥4.2bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥10.1bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.3bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥4.2bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥4.3bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥2.4bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.5bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥2.4bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥2.5bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥91.0bnat 2022-09-30Cons.Assets
Total assets¥96.0bnat 2022-03-31Cons.Assets
Total assets¥97.6bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥45.1bnat 2022-09-30Cons.Liabilities
Total liabilities¥52.1bnat 2022-03-31Cons.Liabilities
Net assets / equity¥45.9bnat 2022-09-30Cons.Net assets
Net assets / equity¥43.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥41.1bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥14.5bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥16.7bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥14.3bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥16.5bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥16.2bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥19.5bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥4.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥10.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥2.6bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥3.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.8bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥5.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥10.0bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥4.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥64.112022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥36.922022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥149.512021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥66.982021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥38.762021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio50.4%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio45.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio42.1%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥181m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥181m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥1.7bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2022-04-01 → 2022-09-30¥75.6bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2022-04-01 → 2022-09-30¥75.6bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥58m
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2022-04-01 → 2022-09-30¥5.1bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥7.0bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥6.9bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥123m
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30¥645m
—segment totalrevenue2022-04-01 → 2022-09-30¥82.6bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥82.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥181m
—segment totalsegment profit2022-04-01 → 2022-09-30¥5.7bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥193m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥193m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥1.7bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2021-04-01 → 2021-09-30¥75.4bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2021-04-01 → 2021-09-30¥75.3bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥40m
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2021-04-01 → 2021-09-30¥5.2bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue2021-04-01 → 2021-09-30¥6.6bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue external2021-04-01 → 2021-09-30¥6.5bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥153m
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentsegment profit2021-04-01 → 2021-09-30¥663m
—segment totalrevenue2021-04-01 → 2021-09-30¥82.0bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥81.8bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥193m
—segment totalsegment profit2021-04-01 → 2021-09-30¥5.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 524
ItemContextValueUnit
Gross profitPrior1YTDDuration10857000000JPY
Gross profitCurrentYTDDuration10856000000JPY
Selling general and administrative expensesPrior1YTDDuration6679000000JPY
Selling general and administrative expensesCurrentYTDDuration6834000000JPY
Operating incomePrior1YTDDuration4177000000JPY
Operating incomeCurrentYTDDuration4022000000JPY
House rent income noiPrior1YTDDuration17000000JPY
House rent income noiCurrentYTDDuration24000000JPY
Commission fee noiPrior1YTDDuration42000000JPY
Commission fee noiCurrentYTDDuration52000000JPY
Insurance premiums refunded cancellation noiPrior1YTDDuration3000000JPY
Insurance premiums refunded cancellation noiCurrentYTDDuration－JPY
Subsidy income noiPrior1YTDDuration9000000JPY
Subsidy income noiCurrentYTDDuration3000000JPY
Guarantee commission received noiPrior1YTDDuration29000000JPY
Guarantee commission received noiCurrentYTDDuration29000000JPY
Cancellation income noiPrior1YTDDuration37000000JPY
Cancellation income noiCurrentYTDDuration－JPY
Other noiPrior1YTDDuration44000000JPY
Other noiCurrentYTDDuration136000000JPY
Non operating incomePrior1YTDDuration184000000JPY
Non operating incomeCurrentYTDDuration246000000JPY
Interest expenses noePrior1YTDDuration52000000JPY
Interest expenses noeCurrentYTDDuration39000000JPY
Other noePrior1YTDDuration35000000JPY
Other noeCurrentYTDDuration55000000JPY
Non operating expensesPrior1YTDDuration87000000JPY
Non operating expensesCurrentYTDDuration94000000JPY
Ordinary incomePrior1YTDDuration4274000000JPY
Ordinary incomeCurrentYTDDuration4174000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration1000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration0JPY
Gain on sales of investment securities eiPrior1YTDDuration0JPY
Gain on sales of investment securities eiCurrentYTDDuration－JPY
Gain on reversal of provision for withdraw loss from employees pension fund eiPrior1YTDDuration71000000JPY
Gain on reversal of provision for withdraw loss from employees pension fund eiCurrentYTDDuration－JPY
Extraordinary incomePrior1YTDDuration73000000JPY
Extraordinary incomeCurrentYTDDuration0JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration18000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration14000000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration0JPY
Loss on sales of noncurrent assets elCurrentYTDDuration3000000JPY
Loss on valuation of subsidiaries stocks elPrior1YTDDuration49000000JPY
Loss on valuation of subsidiaries stocks elCurrentYTDDuration－JPY
Extraordinary lossPrior1YTDDuration67000000JPY
Extraordinary lossCurrentYTDDuration18000000JPY
Income before income taxesPrior1YTDDuration4280000000JPY
Income before income taxesCurrentYTDDuration4156000000JPY
Income taxesPrior1YTDDuration1825000000JPY
Income taxesCurrentYTDDuration1792000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass